Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001862464 | SCV002231023 | uncertain significance | Dyskeratosis congenita, autosomal recessive 6; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4 | 2024-09-11 | criteria provided, single submitter | clinical testing | This sequence change replaces lysine, which is basic and polar, with asparagine, which is neutral and polar, at codon 56 of the PARN protein (p.Lys56Asn). This variant is present in population databases (rs375964590, gnomAD 0.006%). This missense change has been observed in individual(s) with clinical features of pulmonary fibrosis (PMID: 28414520). ClinVar contains an entry for this variant (Variation ID: 834009). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on PARN protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV001862464 | SCV005642680 | uncertain significance | Dyskeratosis congenita, autosomal recessive 6; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4 | 2024-04-22 | criteria provided, single submitter | clinical testing | |
University of Washington Center for Mendelian Genomics, |
RCV001034551 | SCV001197916 | uncertain significance | Pulmonary fibrosis; Familial Interstitial Pneumonia | no assertion criteria provided | research |